Decoding the Heterogeneity of Diffuse Large B-Cell Lymphomas: A Comprehensive Genetic, Transcriptomic, and Phenotypic...

Area of Science:

• Hematology
• Oncology
• Molecular Biology

Background:

• Diffuse large B-cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma, characterized by significant molecular and clinical heterogeneity.
• Current classification systems integrating phenotypic, genetic, and transcriptomic data have improved DLBCL diagnosis and prognosis.
• A comprehensive molecular characterization of DLBCL cell lines is needed to enhance their utility as experimental models.

Purpose of the Study:

• To provide an integrated molecular characterization of 29 DLBCL cell lines by combining phenotypic, genomic, and transcriptomic data.
• To identify genetic subtypes and determine the cell of origin for DLBCL cell lines.
• To dissect molecular heterogeneity and identify potential therapeutic targets within DLBCL subtypes.

Main Methods:

• Utilized fluorescence in situ hybridization, immunohistochemistry, and targeted DNA/RNA sequencing for comprehensive characterization.
• Employed principal component analysis, gene set enrichment analysis (GSEA), differential expression profiling, and regulon analysis to dissect heterogeneity.
• Applied multiple classification algorithms (2-S, LymphGen, DLBclass) for high concordance in genetic subtype assignment.

Main Results:

• Achieved high concordance in genetic subtype assignment across DLBCL cell lines using multiple algorithms.
• Identified distinct molecular signatures, including the DHIT/DZ signature, revealing additional complexity.
• Observed subtype-specific signaling pathway activation, with MCD lines showing increased NF-κB/STAT signaling and EZB/MYC+ lines demonstrating enhanced proliferation.

Conclusions:

• This integrated analysis offers a detailed molecular overview of DLBCL cell lines, validating their importance for mechanistic and therapeutic research.
• The findings underscore the value of combining genetic and transcriptomic analyses for refining DLBCL classification.
• The study provides insights that can guide personalized therapy strategies for DLBCL patients.